On February 22, 2022, Brett Kaplan, M.D., a member of the Board of Directors (the Board) of Compass Therapeutics, Inc. (the Company), notified the Company of his resignation from the Board and all committees thereof, effective February 25, 2022. Dr. Kaplan's resignation was not the result of a disagreement with the Company on any matter relating to the Company's operations, policies or practices.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.145 USD | -4.58% |
|
+4.09% | -26.60% |
28/05 | Compass Therapeutics Appoints Thomas Schuetz as CEO | MT |
28/05 | Compass Therapeutics, Inc. Announces CEO Changes | CI |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-26.60% | 165M | |
+16.21% | 122B | |
+19.78% | 113B | |
+18.95% | 26.49B | |
-23.98% | 19.4B | |
-19.03% | 16.24B | |
-20.71% | 15.4B | |
-46.14% | 15.15B | |
+64.10% | 14.93B | |
+4.56% | 13.52B |
- Stock Market
- Equities
- CMPX Stock
- News Compass Therapeutics, Inc.
- Compass Therapeutics, Inc. Announces Resignation of Brett Kaplan of the Board of Directors